Industry Reports
RBI seeks clarity on FII investment in pharmaceutical sector
The Reserve Bank of India (RBI) has sought clarity on whether foreign portfolio investments can be allowed in existing companies without government approval, putting the spotlight back on a sector that has been the subject of much debate and...
Industry Reports
Medtech companies prepare for an innovation makeover
A report by PricewaterhouseCoopers For decades, the medtech industry was on the forefront of innovation, but now return on innovation investment is declining. Growth through technology innovation has slowed substantially and the benefits from incremental improvements to existing devices...
Industry Reports
Bristol-Myers Squibb reports third quarter 2013 financial results
Bristol-Myers Squibb Company has reported results for the third quarter of 2013 highlighted by the strong performance of key marketed products such as Yervoy, Orencia and Sprycel, the presentation of important clinical data for its immuno-oncology pipeline, and the...
Industry Reports
Abbott reports third-quarter 2013 results
Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013 worldwide sales of $5.4 billion increased 4.3 percent on an operational basis, with strong performance in Diagnostics and Medical Devices. ...
Industry Reports
Adocia announces its Q1 2013 revenues
Adocia , a biotechnology company specialized in the development of ‘best-in-class’ medicines from already approved therapeutic proteins, announces today its Q1 2013 revenues. Detail of the Q1 2013 revenues In thousands of euros...
Industry Reports
Bristol-Myers Squibb reports first quarter 2013 financial results
Bristol-Myers Squibb Company (NYSE: BMY) reported financial results for the first quarter of 2013, and confirmed GAAP EPS and non-GAAP EPS guidance ranges for 2013. Bristol-Myers Squibb posted first quarter 2013 net sales of $3.8 billion, a decrease...
Industry Reports
Abbott reports first-quarter 2013 results
Abbott announced financial results for the first quarter ended March 31, 2013. Worldwide sales of nearly $5.4 billion increased 3.5 percent on an operational basis, consistent with previous guidance, driven by 9.0 percent operational sales growth in Nutrition...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
